Innovation

High Affinity Binding Proteins to Integrins

University of Rochester
posted on 06/23/2009

High Affinity Binding Proteins to Integrins

Suggested Uses

This technology is related to the development of high affinity binding proteins to specific integrin proteins highly associated with cancer metastasis. Applications of these targeting molecules include tumor imaging, targeted tumor therapy, and targeted gene delivery.

Advantages

These molecules are more stable, easier to make, and more amenable to protein engineering techniques than short peptides and antibodies.


Innovation Details
 

Detailed Description

This technology is related to the development of high affinity binding proteins to specific integrin proteins highly associated with cancer metastasis. Applications of these targeting molecules include tumor imaging, targeted tumor therapy, and targeted gene delivery.

These molecules are more stable, easier to make, and more amenable to protein engineering techniques than short peptides and antibodies.

File Number: 6-1014 

Other Information:

  • Refer to: Case # 6-1014
  • Lead Innovator: Dr. Shohei Koide
  • Case Manager: Harl Tolbert, MS, MBA
  • harl_tolbert@urmc.rochester.edu


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Harl Tolbert at University of Rochester for more information.

Request more info via email request more info
People

Case Manager:

Harl Tolbert Harl Tolbert

Innovations (25)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

7,854 members 17,202 innovations 152 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...